Standard
Dose-reduction trials in oncology — aiming for less toxicity and better quality of life at lower costs. / Theilgaard-Mönch, Kim; Ehlers, Lars Holger.
I:
Nature Reviews Clinical Oncology, Bind 21, 2024, s. 81-82.
Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning
Harvard
Theilgaard-Mönch, K & Ehlers, LH 2024, '
Dose-reduction trials in oncology — aiming for less toxicity and better quality of life at lower costs',
Nature Reviews Clinical Oncology, bind 21, s. 81-82.
https://doi.org/10.1038/s41571-023-00831-5
APA
Theilgaard-Mönch, K., & Ehlers, L. H. (2024).
Dose-reduction trials in oncology — aiming for less toxicity and better quality of life at lower costs.
Nature Reviews Clinical Oncology,
21, 81-82.
https://doi.org/10.1038/s41571-023-00831-5
Vancouver
Theilgaard-Mönch K, Ehlers LH.
Dose-reduction trials in oncology — aiming for less toxicity and better quality of life at lower costs.
Nature Reviews Clinical Oncology. 2024;21:81-82.
https://doi.org/10.1038/s41571-023-00831-5
Author
Theilgaard-Mönch, Kim ; Ehlers, Lars Holger. / Dose-reduction trials in oncology — aiming for less toxicity and better quality of life at lower costs. I: Nature Reviews Clinical Oncology. 2024 ; Bind 21. s. 81-82.
Bibtex
@article{b1c1368fa68e42c0987e04a67ce8fedd,
title = "Dose-reduction trials in oncology — aiming for less toxicity and better quality of life at lower costs",
author = "Kim Theilgaard-M{\"o}nch and Ehlers, {Lars Holger}",
note = "Funding Information: The work of K.T.M. is supported by a Novo Nordisk Foundation clinical research fellowship (grant no. 100191) and centre grant (Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, grant no. NNF17CC0027852), by the Danish Council for Strategic Research (grant no. 2034-00089B), the Danish Cancer Society (grant no. R302-A17376), B{\o}rnecancerfonden (2021-7385), the Danish Health Regions, and the Sven Andersen Fonden. The work of L.E. is supported by Nordic Institute of Health Economics A/S. ",
year = "2024",
doi = "10.1038/s41571-023-00831-5",
language = "English",
volume = "21",
pages = "81--82",
journal = "Nature Reviews Clinical Oncology",
issn = "1759-4774",
publisher = "nature publishing group",
}
RIS
TY - JOUR
T1 - Dose-reduction trials in oncology — aiming for less toxicity and better quality of life at lower costs
AU - Theilgaard-Mönch, Kim
AU - Ehlers, Lars Holger
N1 - Funding Information:
The work of K.T.M. is supported by a Novo Nordisk Foundation clinical research fellowship (grant no. 100191) and centre grant (Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, grant no. NNF17CC0027852), by the Danish Council for Strategic Research (grant no. 2034-00089B), the Danish Cancer Society (grant no. R302-A17376), Børnecancerfonden (2021-7385), the Danish Health Regions, and the Sven Andersen Fonden. The work of L.E. is supported by Nordic Institute of Health Economics A/S.
PY - 2024
Y1 - 2024
U2 - 10.1038/s41571-023-00831-5
DO - 10.1038/s41571-023-00831-5
M3 - Comment/debate
C2 - 37845305
AN - SCOPUS:85174318458
VL - 21
SP - 81
EP - 82
JO - Nature Reviews Clinical Oncology
JF - Nature Reviews Clinical Oncology
SN - 1759-4774
ER -
